Free Trial!
Today’s Best Stocks To Trade! Click Here
Repsol YPF S.A. (NYSE: REP | news | PowerRating | PR Charts ) operates as an integrated oil and gas company in Spain. It engages in the exploration, development, and production of crude oil and natural gas; transportation of petroleum products, liquid petroleum gas (LPG), and natural gas; petroleum refining; petrochemical production; and marketing of petroleum products, petroleum derivatives, petrochemicals, LPG, and natural gas. The company also involves in natural gas retailing and electricity generation. It sells gasoline under Repsol, Campsa, and Petronor brand names. The company operates in Argentina, Brazil, Bolivia, and internationally. As of December 31, 2006, it had 1,059,358 thousands of barrels of crude oil; and 8,718,328 millions of cubic feet of gas, as well as 6,806 service stations. Repsol YPF was founded in 1986 and is headquartered in Madrid, Spain. With 1.22 billion shares outstanding and 1.07 million shares declared short as of January 2008, there is no longer a failure to deliver in shares of REP. According to quarterly data provided by the SEC, there were still 13,316 shares of REP that were failing-to-deliver as of September 27, 2007.
U.S. Shipping Partners L.P. (NYSE: USS | news | PowerRating | PR Charts ) provides long-haul marine transportation services to oil and gas companies, primarily for refined petroleum products in the United States. It also engages in the coastwise transportation of petrochemical and commodity chemical products. As of December 31, 2006, the company's fleet consisted of 10 tank vessels, including 6 integrated tug barge units (ITBs), 1 product tanker, and 3 chemical parcel tankers. The company's tank vessels transport refined petroleum products, such as gasoline, jet fuel, diesel fuel, and feedstocks from refineries to terminals and facilities engaged in further processing. Its ITBs primarily transport clean refined petroleum products, such as gasoline, diesel fuel, heating oil, jet fuel, and lubricants from refineries and storage facilities to various destinations, including other refineries and distribution terminals. The company's product tanker carries petroleum products; and parcel tankers transport specialty refined petroleum, petrochemical, and commodity chemical products, such as lubricants, paraxylene, caustic soda, and glycols from refineries and petrochemical manufacturing facilities to other manufacturing facilities and distribution terminals. The company was founded in 1998 and is headquartered in Edison, New Jersey. With 18.24 million shares outstanding and 536,200 shares declared short as of January 2008, there is no longer a failure to deliver in shares of USS. According to quarterly data provided by the SEC, there were still 12,317 shares of USS that were failing-to-deliver as of September 28, 2007.
ASM International N.V. (NASDAQ: ASMI | news | PowerRating | PR Charts ) and its subsidiaries engage in the research, development, manufacture, marketing, and servicing of equipment and materials used to produce semiconductor devices. It provides production solutions in the areas of front-end wafer processing, and back-end assembly and packaging. The company's front-end equipment products include vertical furnace systems, single wafer rapid thermal processing systems, single wafer epitaxy systems, single wafer atomic layer deposition systems, and single wafer plasma processing systems; back-end products comprise die bonding and die sorting systems, flip chip bonding systems, wire bonding, ultrasonic wedge bonding, encapsulation, post encapsulation, and automated systems. ASM International sells its products primarily to manufacturers of semiconductor devices and silicon wafers. It has operations in southeast Asia, Europe, the United States, and Japan. The company, formerly known as Advanced Semiconductor Materials International N.V., was founded in 1968. ASM International is headquartered in Bilthoven, the Netherlands. With 54.01 million shares outstanding and 463,500 shares declared short as of January 2008, there is no longer a failure to deliver in shares of ASMI. According to quarterly data provided by the SEC, there were still 44,755 shares of ASMI that were failing-to-deliver as of September 28, 2007.
deCODE genetics Inc. (NASDAQ: DCGN | news | PowerRating | PR Charts ) operates as a biopharmaceutical company that applies discoveries in human genetics to develop drugs and diagnostics for common diseases. It develops drugs and DNA-based diagnostics based on its discoveries in the inherited causes of common diseases. The company's products include DG031, a Phase II clinical trial product for the treatment of heart attack; DG051, a Phase I clinical trial product for the treatment of heart attack; DG041, a Phase II clinical trial product for the treatment of arterial thrombosis; and CEPH-1347, a Phase II clinical trial product for the treatment of asthma. It also provides drug discovery services to work for fee-for-service customers; protein crystallization products and protein structure analysis contract services; pharmacogenomics and clinical trials services; and DNA analysis services. The company serves pharmaceutical companies, biotechnology firms, pharmacogenomics companies, government institutions, universities, and other research institutions primarily in the United States and Europe. It has strategic alliance with Illumina, Inc. to develop and commercialize molecular diagnostic products; collaboration agreement with F. Hoffmann-La Roche to co-develop inhibitors of PDE4 for the prevention and treatment of vascular disease, including stroke; alliance with Merck & Co, Inc. to develop treatments for obesity; and collaboration agreement with Bayer HealthCare AG to develop, make, and sell DG031. The company was founded in 1996 and is headquartered in Reykjavik, Iceland. With 61.73 million shares outstanding and 2.45 million shares declared short as of January 2008, there is no longer a failure to deliver in shares of DCGN. According to quarterly data provided by the SEC, there were still 43,013 shares of DCGN that were failing-to-deliver as of September 28, 2007.
Somaxon Pharmaceuticals Inc. (NASDAQ: SOMX | news | PowerRating | PR Charts ) a specialty pharmaceutical company, focuses on in-licensing and developing proprietary product candidates for the treatment of diseases and disorders in the fields of psychiatry and neurology. It completed four Phase III clinical trials for its lead product candidate, SILENOR, for the treatment of insomnia. The company also completed a Phase II trial for Nalmefene, which is used for smoking cessation; and a Phase II/III clinical trial for Nalmefene for the treatment of pathological gambling. In addition, it is developing a new formulation of Acamprosate Calcium for the treatment of certain movement disorders. Somaxon Pharmaceuticals was founded in 2003 and is headquartered in San Diego, California. With 18.45 million shares outstanding and 910,500 shares declared short as of January 2008, there is no longer a failure to deliver in shares of SOMX. According to quarterly data provided by the SEC, there were still 14,810 shares of SOMX that were failing-to-deliver as of September 28, 2007.
Telestone Technologies Corp. (NASDAQ: TSTC | news | PowerRating | PR Charts ) provides wireless communications coverage solutions in Vietnam, Indonesia, Malaysia, Thailand, and India. Its wireless coverage solutions include research and development, and application of wireless communications technology. The company provides solutions to the telecommunications industry, which cover indoor and outdoor environments comprising hotels, residential estates, office buildings, airports, exhibition centers, underground stations, highways, and tunnels. Telestone Technologies also offers various wireless communications equipment, including repeaters, antennas, and radio frequency peripherals. In addition, the company provides project design, project management, installation, maintenance, and other after-sales services. The company also offers the 3D solution, which utilizes fiber technology in the radio frequency signal distribution to transmit high speed data signals, and the PHS system optimization solution to address issues related to wireless network, including network coverage, network planning, network capacity and network disturbance. In addition, the company provides 3G applicable equipments, such as WCDMA, CDMA2000, and TD-SCDMA. Its TD-SCDMA repeater application solution could be applied to signal coverage of blind spots, such as signal blocked areas, tunnels, and temporary meeting rooms. Telestone Technologies was founded in 1997 and is headquartered in Beijing, China. With 9.6 million shares outstanding and 358,100 shares declared short as of January 2008, there is no longer a failure to deliver in shares of TSTC. According to quarterly data provided by the SEC, there were still 10,186 shares of TSTC that were failing-to-deliver as of September 28, 2007.
About BUYINS.NET
WWW.BUYINS.NET is a service designed to help bonafide shareholders of publicly traded US companies fight naked short selling. Naked short selling is the illegal act of short selling a stock when no affirmative determination has been made to locate shares of the stock to hypothecate in connection with the short sale. Buyins.net has built a proprietary database that uses Threshold list feeds from NASDAQ, AMEX and NYSE to generate detailed and useful information to combat the naked short selling problem. For the first time, actual trade by trade data is available to the public that shows the attempted size, actual size, price and average value of short sales in stocks that have been shorted and naked shorted. This information is valuable in determining the precise point at which short sellers go out-of-the-money and start losing on their short and naked short trades.
BUYINS.NET has built a massive database that collects, analyzes and publishes a proprietary SqueezeTrigger for each stock that has been shorted, www.buyins.net/squeezetrigger.pdf. The SqueezeTrigger database of nearly 1,800,000,000 short sale transactions goes back to January 1, 2005, and calculates the exact price at which the Total Short Interest is short in each stock. This data was never before available prior to January 1, 2005, because the Self Regulatory Organizations (primary exchanges) guarded it aggressively. After the SEC passed Regulation SHO, exchanges were forced to allow data processors like Buyins.net to access the data.
The SqueezeTrigger database collects individual short trade data on over 7,000 NYSE, AMEX and NASDAQ stocks and general short trade data on nearly 8,000 OTCBB and PINKSHEET stocks. Each month the database grows by approximately 50,000,000 short sale transactions and provides investors with the knowledge necessary to time when to buy and sell stocks with outstanding short positions. By tracking the size and price of each month's short transactions, BUYINS.NET provides institutions, traders, analysts, journalists and individual investors the exact price point where short sellers start losing money.
All material herein was prepared by BUYINS.NET, based upon information believed to be reliable. The information contained herein is not guaranteed by BUYINS.NET to be accurate, and should not be considered to be all-inclusive. The companies that are discussed in this opinion have not approved the statements made in this opinion. This opinion contains forward-looking statements that involve risks and uncertainties. This material is for informational purposes only and should not be construed as an offer or solicitation of an offer to buy or sell securities. BUYINS.NET is not a licensed broker, broker dealer, market maker, investment banker, investment advisor, analyst or underwriter. Please consult a broker before purchasing or selling any securities viewed on or mentioned herein. BUYINS.NET may receive compensation in cash or shares from independent third parties or from the companies mentioned.
BUYINS.NET affiliates, officers, directors and employees may also have bought or may buy the shares discussed in this opinion and may profit in the event those shares rise in value. Market commentary provided by Thomas Ronk.
BUYINS.NET will not advise as to when it decides to sell and does not and will not offer any opinion as to when others should sell; each investor must make that decision based on his or her judgment of the market.
This release contains "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E the Securities Exchange Act of 1934, as amended and such forward-looking statements are made pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. "Forward-looking statements" describe future expectations, plans, results, or strategies and are generally preceded by words such as "may", "future", "plan" or "planned", "will" or "should", "expected," "anticipates", "draft", "eventually" or "projected". You are cautioned that such statements are subject to a multitude of risks and uncertainties that could cause future circumstances, events, or results to differ materially from those projected in the forward-looking statements, including the risks that actual results may differ materially from those projected in the forward-looking statements as a result of various factors, and other risks identified in a companies' annual report on Form 10-K or 10-KSB and other filings made by such company with the Securities and Exchange Commission.
You should consider these factors in evaluating the forward-looking statements included herein, and not place undue reliance on such statements. The forward-looking statements in this release are made as of the date hereof and BUYINS.NET undertakes no obligation to update such statements.
CONTACT: Thomas Ronk, CEO, BUYINS.NET Tel: +1 800 715 9999 e-mail: Tom@buyins.net WWW: http://www.buyins.net
M2 Communications Ltd disclaims all liability for information provided within M2 PressWIRE. Data supplied by named party/parties. Further information on M2 PressWIRE can be obtained at http://www.presswire.net on the world wide web. Inquiries to info@m2.com.
More News:
Market Updates |
Stock Alerts |
All Trading News |
Stock Index
About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback
